Photoaging
Conditions
Keywords
skin microbiome, skin biophysical properties, photoaging, zinc di-(dibutyryl lisinate)
Brief summary
This study is a double-blind randomized vehicle-controlled study assessing how Zinc Di-(dibutyryl lisinate) (Z-DBL) influences skin biophysical measures such as skin hydration, transepidermal water loss, and elasticity, as well as its effects on the skin microbiome of photoaged skin.
Interventions
OTHERTopical Vehicle + Zinc Di-(dibutyryl lisinate)
Instructions: Apply to the entire face twice daily - morning and evening
OTHERTopical Vehicle
Instructions: Apply to the entire face twice daily - morning and evening
Sponsors
Sytheon Ltd.
Integrative Skin Science and Research
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)
Intervention model description
Zinc Di-(dibutyryl lisinate) vs Vehicle
Eligibility
Sex/Gender
FEMALE
Age
40 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
* Females between the ages of 40 years of age until 60 years of age * Participants must have facial fine lines and wrinkles * Subjects must minimize sun exposure * Subjects must avoid professional or facial spa procedures during the study
Exclusion criteria
* Individuals who are pregnant or breastfeeding. * Prisoners. * Adults unable to consent. * Those who are unwilling to discontinue topical hydroquinone, retinoids, bakuchiol, vitamin C, or acetyl zingerone containing products for two weeks to meet the washout criteria prior to enrolling. * Those who are unwilling to discontinue topical antibiotics and benzoyl peroxide for two weeks to meet the washout criteria prior to enrolling. * Those who have been on an oral antibiotic within 1 month prior to enrolling. * Subjects with any of the following facial cosmetic treatments in the past 3 months or those who are unwilling to withhold the following facial cosmetic treatments during the study including botulinum toxin, injectable fillers, microdermabrasion, intense pulsed light (IPL), peels, laser treatments, acid treatments, facial plastic surgery, or any other medical treatment administered by a physician or skin care professional which is designed to improve the appearance of facial skin. * Those who are unwilling to discontinue all facial topical products except the product provided in the study. * Individuals who have changed any of their hormonal based contraception within 3. months prior to joining the study. * Current tobacco smoker or a tobacco smoking history of greater than 10 pack-years.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in image analysis based pigment intensity | 8 weeks | Facial photographs will be analyzed for pigment intensity for the face after the photographs are obtained and analyzed utilizing the BTBP 3D Clarity Pro Facial Modeling and Analysis System (Brigh-Tex BioPhotonics, San Jose, CA, USA). The pigment intensity will be measured as a relative change from baseline and is a dimensionless and normalized measure. |
| Skin Hydration | 8 weeks | The skin capacitance will be measured with a handheld non-invasive device (Skin MoistureMeterSC, Delfin Technologies Ltd.). The measurement is in arbitrary units per manufacturer. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Changes in skin barrier biomarkers like filaggrin | 8 weeks | Measured using D-squame tape strips (CuDerm LLC.) |
| Product tolerability | 8 weeks | Assessed with the use of a tolerability questionnaire to be completed by participants. Tolerability will be measured by rating symptoms such as burning, stinging, and scaling. |
| Change in image analysis based wrinkle severity | 8 weeks | Facial photographs will be obtained and analyzed utilizing the BTBP 3D Clarity Pro Facial Modeling and Analysis System (Brigh-Tex BioPhotonics, San Jose, CA, USA). The measurement will analyze wrinkle severity that is a measure of both the wrinkle depth and width and will be reported as a relative change from baseline. |
| Change in skin transepidermal water loss | 8 weeks | Skin transepidermal water loss measured with a handheld non-invasive device (Vapometer, Delfin Technologies Ltd.) |
| Change in skin elasticity | 8 weeks | Skin elasticity measured with a handheld non-invasive device (Elastimeter, Delfin Technologies Ltd.) |
| Shifts in the skin microbiome diversity | 8 weeks | Whole genome sequencing of the skin microbiome |
Countries
United States
Contacts
Primary ContactRaja K. Sivamani, MD
Backup ContactNasima Afzal
Outcome results
None listed